Progress in translational research on intracerebral hemorrhage: is there an end in sight?

Guohua Xi1, Jennifer Strahle1, Ya Hua1

  • 1Department of Neurosurgery, University of Michigan, Ann Arbor, MI, United States.

Progress in Neurobiology
|October 22, 2013
PubMed

Insights

Intracerebral hemorrhage (ICH) is a deadly stroke subtype lacking specific treatments. This review highlights translational research progress and ongoing clinical trials for ICH, offering hope for new therapies.

Area of Science:

  • Neurology
  • Translational Medicine
  • Stroke Research

Background:

  • Intracerebral hemorrhage (ICH) is a significant cause of stroke-related mortality and disability.
  • Current therapeutic options for ICH are limited, necessitating advancements in understanding and treatment.
  • Translational research is crucial for bridging basic science discoveries to clinical applications in ICH.

Purpose of the Study:

  • To review the progress of translational studies investigating intracerebral hemorrhage (ICH).
  • To cover the etiology, natural history, and impact of ICH on various physiological systems.
  • To discuss current and future clinical trials for ICH management.

Main Methods:

  • Literature review of experimental and translational studies on ICH.
  • Analysis of research on ICH animal models and their relevance.
  • Examination of studies on the immunological and cardiovascular effects of ICH.
  • Synthesis of information on ongoing and proposed clinical trials for ICH.

Main Results:

  • Significant progress has been made in understanding ICH pathophysiology through translational research.
  • Animal models provide valuable insights into ICH mechanisms and potential therapeutic targets.
  • ICH impacts immune and cardiac systems, offering avenues for novel treatment strategies.
  • Several clinical trials are underway or planned to evaluate new ICH interventions.

Conclusions:

  • Translational research is vital for developing effective therapies for intracerebral hemorrhage.
  • Further investigation into ICH's systemic effects and refined clinical trial designs are needed.
  • Advancements in understanding and treatment hold promise for improving outcomes in ICH patients.

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
57
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
41
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
74